A UCF researcher has combined cutting-edge nanoscience with a magnetic phenomenon discovered more than 170 years ago to create a method for speedy medical tests.
The discovery, if commercialized, could lead to faster test results for HIV, Lyme disease, syphilis, rotavirus and other infectious conditions.
“I see no reason why a variation of this technique couldn’t be in every hospital throughout the world,” said Shawn Putnam, an assistant professor in the University of Central Florida’s College of Engineering & Computer Science.
At the core of the research recently published in the academic journal Smallare nanoparticles – tiny particles that are one-billionth of a meter. Putnam’s team coated nanoparticles with the antibody to BSA, or bovine serum albumin, which is commonly used as the basis of a variety of diagnostic tests.
By mixing the nanoparticles in a test solution – such as one used for a blood test – the BSA proteins preferentially bind with the antibodies that coat the nanoparticles, like a lock and key.
That reaction was already well known. But Putnam’s team came up with a novel way of measuring the quantity of proteins present. He used nanoparticles with an iron core and applied a magnetic field to the solution, causing the particles to align in a particular formation. As proteins bind to the antibody-coated particles, the rotation of the particles becomes sluggish, which is easy to detect with laser optics.
The interaction of a magnetic field and light is known as Faraday rotation, a principle discovered by scientist Michael Faraday in 1845. Putnam adapted it for biological use.
“It’s an old theory, but no one has actually applied this aspect of it,” he said.
Other antigens and their unique antibodies could be substituted for the BSA protein used in the research, allowing medical tests for a wide array of infectious diseases.
The proof of concept shows the method could be used to produce biochemical immunology test results in as little as 15 minutes, compared to several hours for ELISA, or enzyme-linked immunosorbent assay, which is currently a standard approach for biomolecule detection.
Receive an email update when we add a new BIOCHEMICAL IMMUNOLOGY TEST article.
The Latest on: Biochemical immunology test
via Google News
The Latest on: Biochemical immunology test
- Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionson January 14, 2021 at 11:37 am
1 Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA. 2 Oral Immunity and ...
- Exposure to Common Foodborne Pathogen Linked to Rare Brain Canceron January 12, 2021 at 2:53 am
A new study suggests a link between toxoplasma gondii (T. gondii) infection and the risk of glioma, a type of brain cancer, in adults. The report finds that people who have glioma are more likely to ...
- Kombucha Inspires Creation of a Microbial “Living Material”on January 11, 2021 at 2:13 pm
In an article published in Cell Metabolism, Moffitt Cancer Center researchers report on a newly discovered biochemical pathway that protects cells from a type of cell death called ferroptosis.
- Albanian Doctors Fret over Private Control of Hospital Labson January 4, 2021 at 10:40 pm
In August, Laboratory Network had taken over three labs at the Mother Theresa hospital – microbiology, immunology and clinical-biochemical ... handle 12,000 PCR tests and serological tests ...
- Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultureson January 4, 2021 at 4:00 am
Bruker Corporation today announce US FDA clearance and the US launch of the MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on ...
- Trisomy 21–induced dysregulation of microglial homeostasis in Alzheimer’s brains is mediated by USP25on January 3, 2021 at 8:14 pm
5 Institute for Immunology, School of Medicine ... P values were determined by one-way ANOVA with Tukey’s post hoc analysis in (E) and by the Kruskal-Wallis test with Dunn’s post hoc analysis in (G) ...
- Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosison January 2, 2021 at 4:00 pm
7 Division of Pulmonary and Critical Care Medicine, Fibrosis Research Center, and Center for Immunology and Inflammatory Diseases ... YAP and TAZ respond to an array of mechanical and biochemical ...
- In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hingeson January 1, 2021 at 4:00 pm
3, 60438 Frankfurt am Main, Germany. 6 Division of Immunology, Paul Ehrlich Institute, Paul Ehrlich Strasse 51-59, 63225 Langen, Germany. 7 German Center for Infection Research, Gießen-Marburg-Langen, ...
- New Treatment Holds Potential to Prevent Crohn's Diseaseon December 23, 2020 at 3:27 am
Some background is needed to understand how and why the triple-punch treatment, which was reported in the journal Science Immunology ... New Genetic Test Can Improve Safety of Inflammatory ...
via Bing News